High frequency of antidrug antibodies and association of random drug levels with efficacy in certolizumab pegol-treated patients with rheumatoid arthritis: results from the BRAGGSS cohort.

Jani, Meghna; Isaacs, John D; Morgan, Ann W; Wilson, Anthony G; Plant, Darren; Hyrich, Kimme L; Chinoy, Hector; Barton, Anne.
Ann Rheum Dis; 76(1): 208-213, 2017 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-27245864